Most-Downgraded StocksMost-DowngradedNYSE:BSX Boston Scientific (BSX) Stock Price, News & Analysis $43.73 -0.61 (-1.37%) Closing price 03:59 PM EasternExtended Trading$44.06 +0.33 (+0.76%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Boston Scientific Stock (NYSE:BSX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Boston Scientific alerts:Sign Up Key Stats Today's Range$43.51▼$44.8650-Day Range$41.55▼$46.0352-Week Range$39.57▼$102.71Volume16.09 million shsAverage Volume18.71 million shsMarket Capitalization$63.39 billionP/E Ratio18.53Dividend YieldN/APrice Target$61.43Consensus RatingModerate Buy Company Overview Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems. Boston Scientific serves healthcare providers and patients around the world. Its portfolio is organized around cardiovascular and MedSurg businesses, reflecting the range of specialties and procedures its products support.AI Generated. May Contain Errors. Read More Boston Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks88th Percentile Overall ScoreBSX MarketRank™: 4.378725659025 of 5 starsBoston Scientific scored higher than 88% of companies evaluated by MarketBeat, and ranked 37th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingBoston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on 1 strong buy rating, 20 buy ratings, 8 hold ratings, and 2 sell ratings.Upside PotentialBoston Scientific has a consensus price target of $61.43, representing about 40.5% upside from its current price of $43.73.Amount of Analyst CoverageBoston Scientific has been the subject of 20 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Boston Scientific's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-2.52% Earnings GrowthEarnings for Boston Scientific are expected to decrease by -2.52% in the coming year, from $3.17 to $3.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Boston Scientific is 18.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.15.Price to Earnings Ratio vs. SectorThe P/E ratio of Boston Scientific is 18.53, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.Price to Earnings Growth RatioBoston Scientific has a PEG Ratio of 1.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBoston Scientific has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Boston Scientific's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.43% of the float of Boston Scientific has been sold short.Short Interest Ratio / Days to CoverBoston Scientific has a short interest ratio ("days to cover") of 1.65, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Boston Scientific has recently decreased by 13.74%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBoston Scientific does not currently pay a dividend.Dividend GrowthBoston Scientific does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.87 News SentimentBoston Scientific has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Boston Scientific this week, compared to 8 articles on an average week.Search InterestOnly 56 people have searched for BSX on MarketBeat in the last 30 days. This is a decrease of -23% compared to the previous 30 days.MarketBeat Follows17 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 89% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Boston Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders0.34% of the stock of Boston Scientific is held by insiders.Percentage Held by Institutions89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Boston Scientific's insider trading history. Receive BSX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSX Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSXNovember 12, 2026 | prnewswire.comBoston Scientific (BSX) Is Back In The Spotlight, What Is Driving Attention?November 12, 2026 | finance.yahoo.comEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 16 at 1:00 AM | Behind the Markets (Ad)Should Boston Scientific (BSX) Investors Worry About These FDA Class II Recalls?November 11, 2026 | finance.yahoo.comBoston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 TranscriptNovember 11, 2026 | seekingalpha.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSXNovember 10, 2026 | globenewswire.com99 Hedge Funds Back This Healthcare Stock: Is It Time to Buy?November 8, 2026 | insidermonkey.comAnalyzing Boston Scientific (NYSE:BSX) & Venus Concept (NASDAQ:VERO)November 7, 2026 | americanbankingnews.comSee More Headlines BSX Stock Analysis - Frequently Asked Questions How have BSX shares performed this year? Boston Scientific's stock was trading at $95.29 at the start of the year. Since then, BSX stock has decreased by 54.1% and is now trading at $43.7340. How were Boston Scientific's earnings last quarter? Boston Scientific Corporation (NYSE:BSX) announced its earnings results on Wednesday, October, 28th. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.73 by $0.00. The company's quarterly revenue was up 1.4% on a year-over-year basis. Read the conference call transcript. Is Boston Scientific buying back stock? Boston Scientific's board authorized a share repurchase program on Monday, May 18th 2026, which authorizes the company to buy back $5 billion in outstanding shares, according to EventVestor. This means that the company could purchase up to 6.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its shares are undervalued. Does Boston Scientific have any subsidiaries? Boston Scientific subsidiaries include these companies: VertiFlex, BTG, Augmenix, Veniti, Claret Medical, Cryterion Medical, nVision Medical, and others. Who are Boston Scientific's major shareholders? Boston Scientific's top institutional investors include State Street Corp (4.64%), Dodge & Cox (1.03%), Assenagon Asset Management S.A. (0.47%) and Toronto Dominion Bank (0.28%). Insiders that own company stock include Michael F Mahoney, Daniel J Brennan, Joseph Michael Fitzgerald, Vance R Brown, Eric Francis Yves Thepaut, Edward J Ludwig, Edward J Ludwig, Wendy Carruthers, Jeffrey B Mirviss, Ellen M Zane, Arthur C Butcher, John Bradley Sorenson, David C Habiger, Yoshiaki Fujimori, Cheryl Pegus and Charles J Dockendorff. View institutional ownership trends. How do I buy shares of Boston Scientific? Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Boston Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Boston Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Intel (INTC), Micron Technology (MU), Tesla (TSLA), Salesforce (CRM) and Visa (V). Company Calendar Last Earnings10/28/2026Today11/16/2026Fiscal Year End12/31/2026Next Earnings (Estimated)2/03/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 BSX's financial health is in the Red zone, according to TradeSmith. BSX has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BSX CIK885725 Webwww.bostonscientific.com Phone(508) 683-4000Fax508-683-5675Employees59,000Year Founded1979Price Target and Rating Average Price Target for Boston Scientific$61.43 High Price Target$118.00 Low Price Target$44.00 Potential Upside/Downside+40.5%Consensus RatingModerate Buy Rating Score (0-4)2.65 Research Coverage31 Analysts Profitability EPS (Trailing Twelve Months)$2.36 Trailing P/E Ratio18.53 Forward P/E Ratio14.15 P/E Growth1.31Net Income$2.90 billion Net Margins16.62% Pretax Margin17.35% Return on Equity18.61% Return on Assets10.58% Debt Debt-to-Equity Ratio0.42 Current Ratio1.36 Quick Ratio0.81 Sales & Book Value Annual Sales$20.07 billion Price / Sales3.16 Cash Flow$3.98 per share Price / Cash Flow10.99 Book Value$16.49 per share Price / Book2.65Miscellaneous Outstanding Shares1,449,470,000Free Float1,444,545,000Market Cap$63.39 billion OptionableOptionable Beta0.60 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSE:BSX) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman and Jensen Huang could one day be worth more than Ap...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.